CS logo
small CS logo
UZ Leuven Campus Gasthuisberg Digestieve Oncologie

Leuven, Belgium
Ziekenhuis in Leuven

About UZ Leuven Campus Gasthuisberg Digestieve Oncologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UZ Leuven Campus Gasthuisberg Digestieve Oncologie


During the past decade, UZ Leuven Campus Gasthuisberg Digestieve Oncologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Leuven Campus Gasthuisberg Digestieve Oncologie" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at UZ Leuven Campus Gasthuisberg Digestieve Oncologie


According to Clinical.Site data, the most researched conditions in "UZ Leuven Campus Gasthuisberg Digestieve Oncologie" are "Metastatic Colorectal Cancer" (2 trials) and "Refractory Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "UZ Leuven Campus Gasthuisberg Digestieve Oncologie" in a lesser frequency.

Clinical Trials Intervention Types at UZ Leuven Campus Gasthuisberg Digestieve Oncologie


Most popular intervention types in "UZ Leuven Campus Gasthuisberg Digestieve Oncologie" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Capecitabine + bevacizumab" (1 trials), "Trifluridine/Tipiracil" (1 trials), "Trifluridine/Tipiracil hydrochloride (S95005)" (1 trials) and "Trifluridine/tipiracil + bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UZ Leuven Campus Gasthuisberg Digestieve Oncologie


The vast majority of trials in "UZ Leuven Campus Gasthuisberg Digestieve Oncologie" are 3 trials for "All" genders.

Clinical Trials Status at UZ Leuven Campus Gasthuisberg Digestieve Oncologie


Currently, there are NaN active trials in "UZ Leuven Campus Gasthuisberg Digestieve Oncologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UZ Leuven Campus Gasthuisberg Digestieve Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UZ Leuven Campus Gasthuisberg Digestieve Oncologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".